NCT07349641 2026-04-13
A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer
National Cancer Institute (NCI)
Phase 2 Not yet recruiting
National Cancer Institute (NCI)
University of Florida
Peking University People's Hospital
New Mexico Cancer Research Alliance
M.D. Anderson Cancer Center
Hackensack Meridian Health
Northwestern University
Washington University School of Medicine